BGMD Financial Statements From 2010 to 2024

BGMDDelisted Stock  USD 0.0002  0.00  0.00%   
BG Medicine financial statements provide useful quarterly and yearly information to potential BG Medicine investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BG Medicine financial statements helps investors assess BG Medicine's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BG Medicine's valuation are summarized below:
BG Medicine does not at this moment have any fundamental measures for analysis.
Check BG Medicine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BGMD main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . BGMD financial statements analysis is a perfect complement when working with BG Medicine Valuation or Volatility modules.
  
This module can also supplement various BG Medicine Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

BG Medicine Company Current Valuation Analysis

BG Medicine's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current BG Medicine Current Valuation

    
  545.97 K  
Most of BG Medicine's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BG Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, BG Medicine has a Current Valuation of 545.97 K. This is 100.0% lower than that of the Life Sciences Tools & Services sector and 99.99% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.

BG Medicine Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BG Medicine's current stock value. Our valuation model uses many indicators to compare BG Medicine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BG Medicine competition to find correlations between indicators driving BG Medicine's intrinsic value. More Info.
BG Medicine is rated below average in return on equity category among related companies. It is rated fourth in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value BG Medicine by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BG Medicine's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BG Medicine's earnings, one of the primary drivers of an investment's value.

About BG Medicine Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include BG Medicine income statement, its balance sheet, and the statement of cash flows. BG Medicine investors use historical funamental indicators, such as BG Medicine's revenue or net income, to determine how well the company is positioned to perform in the future. Although BG Medicine investors may use each financial statement separately, they are all related. The changes in BG Medicine's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BG Medicine's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on BG Medicine Financial Statements. Understanding these patterns can help to make the right decision on long term investment in BG Medicine. Please read more on our technical analysis and fundamental analysis pages.
BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts. BG MEDICINE operates under Medical Instruments Supplies classification in the United States and is traded on PNK Exchange. It employs 5 people.

Pair Trading with BG Medicine

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BG Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BG Medicine will appreciate offsetting losses from the drop in the long position's value.

Moving against BGMD Pink Sheet

  0.58VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.53DOMH Dominari HoldingsPairCorr
  0.47YS YS BiopharmaPairCorr
The ability to find closely correlated positions to BG Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BG Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BG Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BG Medicine to buy it.
The correlation of BG Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BG Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BG Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BG Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in BGMD Pink Sheet

If you are still planning to invest in BG Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BG Medicine's history and understand the potential risks before investing.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance